The third Forum set up under the Ministerial Industry Strategy Group (MISG) met on 3 September 2008. They examined the tools and techniques currently available to enable the pharmaceutical industry and regulators to undertake formalised assessments of the benefits and risks associated with medicines during the lifecycle of the medicine, and what developments were needed to improve on current practice. The Forum also considered how benefit:risk can best be communicated to patients, clinicians and other stakeholders.
The report of the meeting, list of attendees, background documents and presentations given are available below:
MISG Forum report on benefit:risk decision analysis (204Kb)
- please note that an updated version of this paper has now been published, which takes account of a small number of important changes offered by experts present on the day
› List of attendees (9Kb)
MISG Forum presentations - 3 September 2008